SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-002102
Filing Date
2023-02-27
Accepted
2023-02-27 06:45:56
Documents
88
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K plx-20221231x10k.htm   iXBRL 10-K 2228318
2 EX-4.7 plx-20221231xex4d7.htm EX-4.7 18290
3 EX-23.1 plx-20221231xex23d1.htm EX-23.1 7636
4 EX-31.1 plx-20221231xex31d1.htm EX-31.1 11428
5 EX-31.2 plx-20221231xex31d2.htm EX-31.2 11090
6 EX-32.1 plx-20221231xex32d1.htm EX-32.1 5658
7 EX-32.2 plx-20221231xex32d2.htm EX-32.2 5565
8 GRAPHIC plx-20221231x10k001.jpg GRAPHIC 30224
9 GRAPHIC plx-20221231x10k002.jpg GRAPHIC 56468
10 GRAPHIC plx-20221231x10k003.jpg GRAPHIC 62379
11 GRAPHIC plx-20221231x10k005.jpg GRAPHIC 3480
12 GRAPHIC plx-20221231xex23d1001.jpg GRAPHIC 4679
  Complete submission text file 0001558370-23-002102.txt   8669084

Data Files

Seq Description Document Type Size
13 EX-101.SCH plx-20221231.xsd EX-101.SCH 60870
14 EX-101.CAL plx-20221231_cal.xml EX-101.CAL 55273
15 EX-101.DEF plx-20221231_def.xml EX-101.DEF 258800
16 EX-101.LAB plx-20221231_lab.xml EX-101.LAB 427734
17 EX-101.PRE plx-20221231_pre.xml EX-101.PRE 420983
82 EXTRACTED XBRL INSTANCE DOCUMENT plx-20221231x10k_htm.xml XML 1233008
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 23669985
SIC: 2836 Biological Products, (No Diagnostic Substances)